Lithium carbonate-gluten intolerance.
Lumley
F
F
D018692:Antimanic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002446:Celiac Disease / Q000097:blood / Q000139:chemically induced*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D014677:Pharmaceutical Vehicles; D013810:Therapeutic Equivalency; D014908:Triticum / Q000009:adverse effects
D018692:Antimanic Agents; D003692:Delayed-Action Preparations; D014677:Pharmaceutical Vehicles; D016651:Lithium Carbonate